William E. Evans
Impact in
-
- Acute Lymphoblastic Leukemia research
- Pharmacology top 5%
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Acute Lymphoblastic Leukemia research 6
-
- Cancer therapeutics and mechanisms 1
- Biochemical and Molecular Research 1
- Co-authors
- Hung-Liang Tai (2 shared papers)Eugene Y. Krynetski (2 shared papers)Michael Y. Fessing (2 shared papers)Ching‐Hon Pui (2 shared papers)Thrina Loennechen (1 shared paper)Mary V. Relling (1 shared paper)Charles R. Yates (1 shared paper)Alessandra d’Azzo (1 shared paper)
- Journals
- Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy (2 papers)Advances in experimental medicine and biology (1 paper)Pharmacogenetics and Genomics (1 paper)Leukemia Research (1 paper)Annals of Internal Medicine (1 paper)
- Partner nations
- United StatesChinaUnited Kingdom
In The Last Decade
William E. Evans
7 papers receiving 737 citations
William E. Evans's Hit Papers
Peers
Comparison fields: 5 of 72
- Public Health, Environmental and Occupational Health 434
- Pharmacology 136
- Transplantation 39
- Pediatrics, Perinatology and Child Health 184
- Speech and Hearing 61
Countries citing papers authored by William E. Evans
This map shows the geographic impact of William E. Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Evans more than expected).
Fields of papers citing papers by William E. Evans
This network shows the impact of papers produced by William E. Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Evans. The network helps show where William E. Evans may publish in the future.
Co-authors
The 15 scholars most cited alongside William E. Evans, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Molecular Diagnosis of Thiopurine S-Methyltransferase Deficiency: Genetic Basis for Azathioprine and Mercaptopurine Intolerance Hit paper breakdown → | 1997 | 585 |
| 2 | 1999 | 99 | |
| 3 | 1977 | 40 | |
| 4 | 1994 | 21 | |
| 5 | 1992 | 12 | |
| 6 | 1999 | 6 | |
| 7 | 1990 | 5 |
About William E. Evans
William E. Evans is a scholar working on Public Health, Environmental and Occupational Health, Molecular Biology, Pediatrics, Perinatology and Child Health, Hematology and Health, Toxicology and Mutagenesis, having authored 7 papers that have together received 768 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (6 papers), Acute Myeloid Leukemia Research (2 papers), Childhood Cancer Survivors' Quality of Life (2 papers), Cancer therapeutics and mechanisms (1 paper), Chronic Myeloid Leukemia Treatments (1 paper), Heavy Metal Exposure and Toxicity (1 paper) and Biochemical and Molecular Research (1 paper). The work is most often cited by research in Public Health, Environmental and Occupational Health (434 citations), Pharmacology (136 citations), Transplantation (39 citations), Pediatrics, Perinatology and Child Health (184 citations) and Speech and Hearing (61 citations). William E. Evans has collaborated with scholars based in United States, China and United Kingdom. Frequent co-authors include Hung-Liang Tai, Eugene Y. Krynetski, Michael Y. Fessing, Ching‐Hon Pui, Thrina Loennechen, Mary V. Relling, Charles R. Yates, Alessandra d’Azzo, Yu‐Yan Yeh and Helen S. L. Chan. Their work appears in journals such as Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy, Advances in experimental medicine and biology, Pharmacogenetics and Genomics, Leukemia Research and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.